Christina Kapizioni
Christina Kapizioni publishes mostly in Genetics, Surgery and Epidemiology, on topics such as Inflammatory Bowel Disease, Microscopic Colitis and Clostridium difficile and Clostridium perfringens research.
- World rank
- #1,008,202 of 7,710,434 ranked researchers
- Rank in Greece
- #3,923 of 33,280
- Works
- 34
- Citations
- 730
- Citations per work
- 21.5
What does Christina Kapizioni research?
Christina Kapizioni's work is mostly in Medicine (57%), Biochemistry, Genetics and Molecular Biology (20%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1957.1%
- Medicine1957.1%
- Everything else822.5%
- Life Sciences720.4%
- 1Genetics20% of their works
- 2Surgery17% of their works
- 3Epidemiology15% of their works
- 4Infectious Diseases11% of their works
- 5Pulmonary and Respiratory Medicine9% of their works
- 6Rheumatology5% of their works
Research topics
- Inflammatory Bowel Disease
- Microscopic Colitis
- Clostridium difficile and Clostridium perfringens research
- Gastric Cancer Management and Outcomes
- Gastrointestinal Tumor Research and Treatment
- Helicobacter pylori-related gastroenterology studies
- Biosimilars and Bioanalytical Methods
- Rheumatoid Arthritis Research and Therapies
Which keywords describe Christina Kapizioni's research?
The keywords of their largest research topics: Inflammatory Bowel Disease, Epidemiology, Pathogenesis, Crohn's Disease, Ulcerative Colitis, Clinical Practice Guidelines, Collagenous Colitis and Microscopic Colitis.
- Rheumatoid Arthritis
- Biosimilars
- Sunitinib
- Helicobacter pylori
- Fecal Microbiota Transplantation
- Chemotherapy
- Inflammation
- Microscopic Colitis
- Clinical Practice Guidelines
- Crohn's Disease
- Epidemiology
- Inflammatory Bowel Disease
- Pathogenesis
- Ulcerative Colitis
- Collagenous Colitis
- Gastric Cancer
- Antibiotic-Associated Diarrhea
- Endoscopic Resection
- Antibiotic Resistance
- Imatinib Mesylate
- Biological Therapy
- Immunogenicity
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Inflammatory Bowel Disease312 topics
- Epidemiology252 topics
- Pathogenesis232 topics
- Crohn's Disease191 topic
- Ulcerative Colitis191 topic
- Clinical Practice Guidelines122 topics
- Collagenous Colitis121 topic
- Microscopic Colitis121 topic
- Gastric Cancer102 topics
- Inflammation72 topics
- Antibiotic-Associated Diarrhea61 topic
- Chemotherapy61 topic
- Endoscopic Resection61 topic
- Fecal Microbiota Transplantation61 topic
- Antibiotic Resistance41 topic
- Helicobacter pylori41 topic
- Imatinib Mesylate41 topic
- Sunitinib41 topic
- Biological Therapy31 topic
- Biosimilars31 topic
- Immunogenicity31 topic
- Rheumatoid Arthritis31 topic
Where does Christina Kapizioni work?
Christina Kapizioni's main affiliation in the publication record is Tzaneion General Hospital, Greece.
How many publications and citations does Christina Kapizioni have?
OpenAlex counts 34 works and 730 citations for Christina Kapizioni, an h-index of 12, ranking #1,008,202 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Christina Kapizioni. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.